These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36918462)

  • 1. Caffeine plus haloperidol reduces fatigue in an experimental model of Parkinson's disease - a prospective to A
    de Bem Alves AC; Aguiar AS
    Purinergic Signal; 2024 Feb; 20(1):29-34. PubMed ID: 36918462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mGlu
    Romero-Fernandez W; Taura JJ; Crans RAJ; Lopez-Cano M; Fores-Pons R; Narváez M; Carlsson J; Ciruela F; Fuxe K; Borroto-Escuela DO
    Mol Neurobiol; 2022 Oct; 59(10):5955-5969. PubMed ID: 35829830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
    Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
    Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
    Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
    Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist.
    Aoyama S; Kase H; Borrelli E
    J Neurosci; 2000 Aug; 20(15):5848-52. PubMed ID: 10908627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric Interactions between Adenosine A
    Prasad K; de Vries EFJ; Elsinga PH; Dierckx RAJO; van Waarde A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A
    Ferré S; Bonaventura J; Zhu W; Hatcher-Solis C; Taura J; Quiroz C; Cai NS; Moreno E; Casadó-Anguera V; Kravitz AV; Thompson KR; Tomasi DG; Navarro G; Cordomí A; Pardo L; Lluís C; Dessauer CW; Volkow ND; Casadó V; Ciruela F; Logothetis DE; Zwilling D
    Front Pharmacol; 2018; 9():243. PubMed ID: 29686613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
    Xu K; Di Luca DG; Orrú M; Xu Y; Chen JF; Schwarzschild MA
    Neuroscience; 2016 May; 322():129-37. PubMed ID: 26905951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique effect of clozapine on adenosine A
    Valle-León M; Casajuana-Martin N; Del Torrent CL; Argerich J; Gómez-Acero L; Sahlholm K; Ferré S; Pardo L; Ciruela F
    Biomed Pharmacother; 2023 Apr; 160():114327. PubMed ID: 36736280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased striatal adenosine A
    Valle-León M; Callado LF; Aso E; Cajiao-Manrique MM; Sahlholm K; López-Cano M; Soler C; Altafaj X; Watanabe M; Ferré S; Fernández-Dueñas V; Menchón JM; Ciruela F
    Neuropsychopharmacology; 2021 Feb; 46(3):665-672. PubMed ID: 33010795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute cocaine treatment enhances the antagonistic allosteric adenosine A2A-dopamine D2 receptor-receptor interactions in rat dorsal striatum without increasing significantly extracellular dopamine levels.
    Romero-Fernandez W; Zhou Z; Beggiato S; Wydra K; Filip M; Tanganelli S; Borroto-Escuela DO; Ferraro L; Fuxe K
    Pharmacol Rep; 2020 Apr; 72(2):332-339. PubMed ID: 32124388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic-Like Efficacy of Dopamine D
    Sahlholm K; Gómez-Soler M; Valle-León M; López-Cano M; Taura JJ; Ciruela F; Fernández-Dueñas V
    Mol Neurobiol; 2018 Jun; 55(6):4952-4958. PubMed ID: 28779351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boolean analysis shows a high proportion of dopamine D
    Rivas-Santisteban R; Rico AJ; Muñoz A; Rodríguez-Pérez AI; Reyes-Resina I; Navarro G; Labandeira-García JL; Lanciego JL; Franco R
    Neurobiol Dis; 2023 Nov; 188():106341. PubMed ID: 37918757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia.
    Napolitano F; Pasqualetti M; Usiello A; Santini E; Pacini G; Sciamanna G; Errico F; Tassone A; Di Dato V; Martella G; Cuomo D; Fisone G; Bernardi G; Mandolesi G; Mercuri NB; Standaert DG; Pisani A
    Neurobiol Dis; 2010 Jun; 38(3):434-45. PubMed ID: 20227500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A
    Alves ACB; Santos NS; Santos APT; da Panatta G; Speck AE; Cunha RA; Aguiar AS
    Front Pharmacol; 2024; 15():1390187. PubMed ID: 38860172
    [No Abstract]   [Full Text] [Related]  

  • 17. New Developments on the Adenosine Mechanisms of the Central Effects of Caffeine and Their Implications for Neuropsychiatric Disorders.
    Ferré S; Díaz-Ríos M; Salamone JD; Prediger RD
    J Caffeine Adenosine Res; 2018 Dec; 8(4):121-131. PubMed ID: 30596206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease.
    Fuxe K; Guidolin D; Agnati LF; Borroto-Escuela DO
    Expert Opin Ther Targets; 2015 Mar; 19(3):377-98. PubMed ID: 25486101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Habit Formation after Random Interval Training Is Associated with Increased Adenosine A
    He Y; Li Y; Chen M; Pu Z; Zhang F; Chen L; Ruan Y; Pan X; He C; Chen X; Li Z; Chen JF
    Front Mol Neurosci; 2016; 9():151. PubMed ID: 28082865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adenosine receptor--relation to dopaminergic system].
    Mishina M; Ishii K; Ishiwata K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):835-7. PubMed ID: 18210811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.